These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 33404371)
61. COVID-19 in non-healthcare workplace settings in NSW, Australia. Khanlari S; Johnstone T; Witteveen-Roberts A; Nassar N; Aust N Z J Public Health; 2022 Dec; 46(6):751-757. PubMed ID: 36190190 [TBL] [Abstract][Full Text] [Related]
62. Genomics, social media and mobile phone data enable mapping of SARS-CoV-2 lineages to inform health policy in Bangladesh. Cowley LA; Afrad MH; Rahman SIA; Mamun MMA; Chin T; Mahmud A; Rahman MZ; Billah MM; Khan MH; Sultana S; Khondaker T; Baker S; Banik N; Alam AN; Mannoor K; Banu S; Chowdhury A; Flora MS; Thomson NR; Buckee CO; Qadri F; Shirin T Nat Microbiol; 2021 Oct; 6(10):1271-1278. PubMed ID: 34497354 [TBL] [Abstract][Full Text] [Related]
63. Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review. Stratil JM; Biallas RL; Burns J; Arnold L; Geffert K; Kunzler AM; Monsef I; Stadelmaier J; Wabnitz K; Litwin T; Kreutz C; Boger AH; Lindner S; Verboom B; Voss S; Movsisyan A Cochrane Database Syst Rev; 2021 Sep; 9(9):CD015085. PubMed ID: 34523727 [TBL] [Abstract][Full Text] [Related]
64. COVID-19, Australia: Epidemiology Report 16 (Reporting week to 23:59 AEST 17 May 2020). COVID-19 National Incident Room Surveillance Team Commun Dis Intell (2018); 2020 May; 44():. PubMed ID: 32522141 [TBL] [Abstract][Full Text] [Related]
65. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia. Adegbija O; Walker J; Smoll N; Khan A; Graham J; Khandaker G Commun Dis Intell (2018); 2021 Feb; 45():. PubMed ID: 33632091 [TBL] [Abstract][Full Text] [Related]
66. Associations between changes in population mobility in response to the COVID-19 pandemic and socioeconomic factors at the city level in China and country level worldwide: a retrospective, observational study. Liu Y; Wang Z; Rader B; Li B; Wu CH; Whittington JD; Zheng P; Stenseth NC; Bjornstad ON; Brownstein JS; Tian H Lancet Digit Health; 2021 Jun; 3(6):e349-e359. PubMed ID: 34045001 [TBL] [Abstract][Full Text] [Related]
67. Harnessing testing strategies and public health measures to avert COVID-19 outbreaks during ocean cruises. Chowell G; Dahal S; Bono R; Mizumoto K Sci Rep; 2021 Jul; 11(1):15482. PubMed ID: 34326439 [TBL] [Abstract][Full Text] [Related]
68. Perfect as the enemy of good: tracing transmissions with low-sensitivity tests to mitigate SARS-CoV-2 outbreaks. Kennedy-Shaffer L; Baym M; Hanage WP Lancet Microbe; 2021 May; 2(5):e219-e224. PubMed ID: 33748803 [TBL] [Abstract][Full Text] [Related]
69. Temporal variations in international air travel: implications for modelling the spread of infectious diseases. Wardle J; Bhatia S; Cori A; Nouvellet P J Travel Med; 2024 Jun; 31(4):. PubMed ID: 38630887 [TBL] [Abstract][Full Text] [Related]
70. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461 [TBL] [Abstract][Full Text] [Related]
72. Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study. Kiang MV; Chin ET; Huynh BQ; Chapman LAC; Rodríguez-Barraquer I; Greenhouse B; Rutherford GW; Bibbins-Domingo K; Havlir D; Basu S; Lo NC Lancet Infect Dis; 2021 Jul; 21(7):929-938. PubMed ID: 33765417 [TBL] [Abstract][Full Text] [Related]
73. Understanding the impact of mobility on COVID-19 spread: A hybrid gravity-metapopulation model of COVID-19. Iyaniwura SA; Ringa N; Adu PA; Mak S; Janjua NZ; Irvine MA; Otterstatter M PLoS Comput Biol; 2023 May; 19(5):e1011123. PubMed ID: 37172027 [TBL] [Abstract][Full Text] [Related]
74. The Interplay Between Policy and COVID-19 Outbreaks in South Asia: Longitudinal Trend Analysis of Surveillance Data. Welch SB; Kulasekere DA; Prasad PVV; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh L; White J; Issa TZ; Culler K; Boctor MJ; Mason M; Oehmke JF; Faber JMM; Post LA JMIR Public Health Surveill; 2021 Jun; 7(6):e24251. PubMed ID: 34081593 [TBL] [Abstract][Full Text] [Related]
75. Heterogeneity in testing, diagnosis and outcome in SARS-CoV-2 infection across outbreak settings in the Greater Toronto Area, Canada: an observational study. Wang L; Ma H; Yiu KCY; Calzavara A; Landsman D; Luong L; Chan AK; Kustra R; Kwong JC; Boily MC; Hwang S; Straus S; Baral SD; Mishra S CMAJ Open; 2020; 8(4):E627-E636. PubMed ID: 33037070 [TBL] [Abstract][Full Text] [Related]
76. COVID-19, Australia: Epidemiology Report 12 (Reporting week to 23:59 AEST 19 April 2020). COVID-19 National Incident Room Surveillance Team Commun Dis Intell (2018); 2020 Apr; 44():. PubMed ID: 32343939 [TBL] [Abstract][Full Text] [Related]
77. Using after-action reviews of outbreaks to enhance public health responses: lessons for COVID-19. Dalton CB; Kirk MD; Durrheim DN Med J Aust; 2022 Jan; 216(1):4-9. PubMed ID: 34554574 [No Abstract] [Full Text] [Related]
78. Cruise Ship Travel in the Era of Coronavirus Disease 2019 (COVID-19): A Summary of Outbreaks and a Model of Public Health Interventions. Guagliardo SAJ; Prasad PV; Rodriguez A; Fukunaga R; Novak RT; Ahart L; Reynolds J; Griffin I; Wiegand R; Quilter LAS; Morrison S; Jenkins K; Wall HK; Treffiletti A; White SB; Regan J; Tardivel K; Freeland A; Brown C; Wolford H; Johansson MA; Cetron MS; Slayton RB; Friedman CR Clin Infect Dis; 2022 Feb; 74(3):490-497. PubMed ID: 33978720 [TBL] [Abstract][Full Text] [Related]
79. Public transit mobility as a leading indicator of COVID-19 transmission in 40 cities during the first wave of the pandemic. Soucy JR; Sturrock SL; Berry I; Westwood DJ; Daneman N; Fisman D; MacFadden DR; Brown KA PeerJ; 2024; 12():e17455. PubMed ID: 38832041 [TBL] [Abstract][Full Text] [Related]
80. Estimating COVID Risk During a Period of Pandemic Decline. Inglis TJJ; McFadden B; Macali A Front Public Health; 2021; 9():744819. PubMed ID: 34976916 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]